4//SEC Filing
Valamehr Bahram 4
Accession 0000950170-25-102979
CIK 0001434316other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:02 PM ET
Size
5.4 KB
Accession
0000950170-25-102979
Insider Transaction Report
Form 4
Valamehr Bahram
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-08-04$1.06/sh−14,466$15,396→ 334,898 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $1.04 to $1.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001748177
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:02 PM ET
- Size
- 5.4 KB